Related Experiment Video

Updated: Aug 9, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Exploring a new twist on tumor metastasis

Jing Yang1, Sendurai A Mani, Robert A Weinberg

  • 1Whitehead Institute for Biomedical Research, Cambridge Center, Cambridge, Massachusetts 02142, USA.

Cancer Research
|May 3, 2006
PubMed

Insights

Understanding the transcription factor Twist and epithelial-mesenchymal transition is key to limiting cancer metastasis. This review explores their roles in normal development and tumor progression.

Area of Science:

  • Oncology
  • Developmental Biology
  • Molecular Biology

Background:

  • Cancer metastasis is a major cause of cancer-related deaths.
  • The transcription factor Twist plays a role in tumor cell metastasis.
  • Epithelial-mesenchymal transition (EMT) is a process involved in metastasis.

Purpose of the Study:

  • To review the Twist signaling pathway during normal development.
  • To discuss the role of Twist and EMT in tumor metastasis.

Main Methods:

  • Literature review of studies on Twist signaling and EMT.
  • Analysis of the biological functions of Twist and EMT in cancer.

Main Results:

  • Twist regulates epithelial-mesenchymal transition.
  • Twist is involved in early embryonic morphogenesis.
  • EMT and Twist play critical roles in tumor metastasis.

Conclusions:

  • Understanding the genetic programs driving metastasis, particularly the Twist pathway and EMT, is crucial for developing strategies to prevent or limit cancer spread.
  • Targeting Twist and EMT may offer therapeutic avenues for cancer treatment.

More Related Videos

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs07:31

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...